(19)
(11) EP 4 022 313 A1

(12)

(43) Date of publication:
06.07.2022 Bulletin 2022/27

(21) Application number: 20765196.9

(22) Date of filing: 20.08.2020
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
G01N 1/28(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/574; G01N 2800/52; G01N 2333/70596; G01N 1/30; G01N 1/06; G01N 1/36; G01N 1/42; C07K 16/2827
(86) International application number:
PCT/DK2020/050236
(87) International publication number:
WO 2021/037319 (04.03.2021 Gazette 2021/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2019 US 201962893883 P

(71) Applicant: Y-Mabs Therapeutics, Inc.
New York NY 10169 (US)

(72) Inventors:
  • SEQUEIRA, Sonia
    Verona, New Jersey 07044 (US)
  • MAHIUDDIN, Ahmed
    Verona, New Jersey 07044 (US)
  • J. MØLLER SAN-PEDRO, Claus
    2100 København Ø (DK)

(74) Representative: Valua 
Valua ApS Borgmester Jensens Allé 25C, 1. sal
2100 Copenhagen
2100 Copenhagen (DK)

   


(54) IMMUNOHISTOCHEMICAL ASSESSMENT OF B7-H3 EXPRESSION